CoChat
Sign Up
Cited by 236

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Stem cells: the intestinal stem cell as a paradigm

Bach, Simon P., Renehan, Andrew G., Potten, Christopher S.·2000·Carcinogenesis
DOI 10.1093/carcin/21.3.469
Open this paper in CoChat — free account

Abstract

Stem cell research provides a foundation for therapeutic advancement in oncology, clinical genetics and a diverse array of degenerative disorders. For example, the elucidation of pathways governing proliferative regulation and differentiation within cellular systems will result in medical strategies aimed at the root cause of cancer. At present the characterization of reliable stem cell markers is the immediate aim in this particular field. Over the past 30 years investigators have determined many of the physical and functional properties of stem cells through careful and imaginative experimentation. Intestinal stem cells reside at the crypt base and give rise to all cell types found within the crypt. They readily undergo altruistic apoptosis in response to toxic stimuli although their progeny are hardier and will regain stem cell function to repopulate the tissue compartment, giving rise to the concept of a proliferative hierarchy. Contention exists when deciding whether the full complement of cells within a crypt is derived from either a single or multiple stems. Evidence has also arisen to challenge the long held view that colorectal tumours arise from a single mutated stem cell, as early adenomas from a human XO/XY mosaic contained distinct clones. Mechanisms governing the stem cell cycle and subsequent proliferative activity largely remain obscure. The adenomatous polyposis coli gene product has, however, been shown to promote the degradation of beta-catenin, an enhancer…

Overview

Integrity signals

Registry

Crossref · 10.1093/carcin/21.3.469

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 73

  1. Potten,C.S. and Loeffler,M. (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development, 110, 1001–1020. · DOI
  2. Potten,C.S., Roberts,S.A., Chwalinski,S., Loeffler,M. and Paulus,U. (1988) Scoring mitotic activity in longitudinal sections of crypts of the small intestine. Cell Tissue Kinet., 21, 231–246. · DOI
  3. Potten,C.S. (1986) Cell cycles in cell hierarchies. Int. J. Radiat. Biol. Rel. Stud. Phys. Chem. Med., 49, 257–278. · DOI
  4. Potten,C.S., Owen,G. and Roberts,S.A. (1990) The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int. J. Radiat. Biol., 57, 185–199. · DOI
  5. Potten,C.S., Kellett,M., Roberts,S.A., Rew,D.A. and Wilson,G.D. (1992) Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut, 33, 71–78. · DOI
  6. Kaur,P. and Potten,C.S. (1986) Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity. Cell Tissue Kinet., 19, 601–610. · DOI
  7. Al-Dewachi,H.S., Wright,N.A., Appleton,D.R. and Watson,A.J. (1977) The effect of a single injection of hydroxyurea on cell population kinetics in the small bowel mucosa of the rat. Cell Tissue Kinet., 10, 203–213. · DOI
  8. Hendry,J.H., Potten,C.S., Ghafoor,A., Moore,J.V., Roberts,S.A. and Williams,P.C. (1989) The response of murine intestinal crypts to short-range promethium-147 beta irradiation: deductions concerning clonogenic cell numbers and positions. Radiat. Res., 118, 364–374. · DOI
  9. Ponder,B.A., Schmidt,G.H., Wilkinson,M.M., Wood,M.J., Monk,M. and Reid,A. (1985) Derivation of mouse intestinal crypts from single progenitor cells. Nature, 313, 689–691. · DOI
  10. Schmidt,G.H., Winton,D.J. and Ponder,B.A. (1988) Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development, 103, 785–790. · DOI
  11. Winton,D.J., Blount,M.A. and Ponder,B.A. (1988) A clonal marker induced by mutation in mouse intestinal epithelium. Nature, 333, 463–466. · DOI
  12. Loeffler,M., Birke,A., Winton,D. and Potten,C. (1993) Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J. Theor. Biol., 160, 471–491. · DOI
  13. Potten,C.S. and Loeffler,M. (1987) A comprehensive model of the crypts of the small intestine of the mouse provides insight into the mechanisms of cell migration and the proliferation hierarchy. J. Theor. Biol., 127, 381–391. · DOI
  14. Withers,H.R. and Elkind,M.M. (1970) Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Radiat. Biol. Rel. Stud. Phys. Chem. Med., 17, 261–267. · DOI
  15. Hendry,J.H., Roberts,S.A. and Potten,C.S. (1992) The clonogen content of murine intestinal crypts: dependence on radiation dose used in its determination. Radiat. Res., 132, 115–119. · DOI
  16. Cai,W.B., Roberts,S.A. and Potten,C.S. (1997) The number of clonogenic cells in crypts in three regions of murine large intestine. Int. J. Radiat. Biol., 71, 573–579. · DOI
  17. Potten,C.S. (1977) Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature, 269, 518–521. · DOI
  18. Hendry,J.H. (1979) A new derivation, from split-dose data, of the complete survival curve for clonogenic normal cells in vivo. Radiat. Res., 78, 404–414. · DOI
  19. Roberts,S.A. and Potten,C.S. (1994) Clonogen content of intestinal crypts: its deduction using a microcolony assay on whole mount preparations and its dependence on radiation dose. Int. J. Radiat. Biol., 65, 477–481. · DOI
  20. Roberts,S.A., Hendry,J.H. and Potten,C.S. (1995) Deduction of the clonogen content of intestinal crypts: a direct comparison of two-dose and multiple-dose methodologies. Radiat. Res., 141, 303–308. · DOI
  21. Cox,W.F.Jr and Pierce,G.B. (1982) The endodermal origin of the endocrine cells of an adenocarcinoma of the colon of the rat. Cancer, 50, 1530–1538. · DOI
  22. Kirkland,S.C. (1988) Clonal origin of columnar, mucous and endocrine cell lineages in human colorectal epithelium. Cancer, 61, 1359–1363. · DOI
  23. Wright,N.A. (1997) Stem cell repertoire in the intestine. In Potten,C.S. (ed.) Stem Cells. Academic Press, London. pp. 315–330. · DOI
  24. Bjerknes,M. and Cheng,H. (1999) Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology, 116, 7–14. · DOI
  25. Potten,C.S., Schofield,R. and Lajtha,L.G. (1979) A comparison of cell replacement in bone marrow, testis and three regions of surface epithelium. Biochim. Biophys. Acta, 560, 281–299. · DOI
  26. Bjerknes,M. and Cheng,H. (1981) The stem-cell zone of the small intestinal epithelium. I. Evidence from Paneth cells in the adult mouse. Am. J. Anat., 160, 51–63. · DOI
  27. Bjerknes,M. and Cheng,H. (1981) The stem-cell zone of the small intestinal epithelium. III. Evidence from columnar, enteroendocrine and mucous cells in the adult mouse. Am. J. Anat., 160, 77–91. · DOI
  28. Korinek,V., Barker,N., Moerer,P., van Donselaar,E., Huls,G., Peters,P.J. and Clevers,H. (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet., 19, 379–383. · DOI
  29. Potten,C.S., Al-Barwari,S.E., Hume,W.J. and Searle,J. (1977) Circadian rhythms of presumptive stem cells in three different epithelia of the mouse. Cell Tissue Kinet., 10, 557–568. · DOI
  30. Potten,C.S. (1992) The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev., 11, 179–195. · DOI
  31. Clarke,A.R., Howard,L.A., Harrison,D.J. and Winton,D.J. (1997) p53, mutation frequency and apoptosis in the murine small intestine. Oncogene, 14, 2015–2018. · DOI
  32. Merritt,A.J., Potten,C.S., Watson,A.J., Loh,D.Y., Nakayama,K. and Hickman,J.A. (1995) Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell, Sci., 108, 2261–2271. · DOI
  33. Heddle,J.A., Consentino,L., Dawod,G., Swiger,R.R. and Paashuis-Lew,Y. (1996) Why do stem cells exist? Environ. Mol. Mutagen., 28, 334–341. · DOI
  34. Pritchard,D.M., Jackman,A., Potten,C.S. and Hickman,J.A. (1998) Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. Toxicol. Lett., 102–103, 19–27. · DOI
  35. Watson,A.J., Merritt,A.J., Jones,L.S., Askew,J.N., Anderson,E., Becciolini,A., Balzi,M., Potten,C.S. and Hickman,J.A. (1996) Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br. J. Cancer, 73, 889–895. · DOI
  36. Wilson,J.W., Nostro,M.C., Balzi,M., Faraoni,P., Cianchi,F., Becciolini,A. and Potten,C.S. (2000) Bcl-w expression in colorectal adenocarcinoma. Br. J. Cancer, 82, 178–185. · DOI
  37. Kinzler,K.W. and Vogelstein,B. (1998) Landscaping the cancer terrain. Science, 280, 1036–1037. · DOI
  38. Behrens,J., Jerchow,B.A., Wurtele,M., Grimm,J., Asbrand,C., Wirtz,R., Kuhl,M., Wedlich,D. and Birchmeier,W. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC and GSK3beta. Science, 280, 596–599. · DOI
  39. Korinek,V., Barker,N., Willert,K., Molenaar,M., Roose,J., Wagenaar,G., Markman,M., Lamers,W., Destree,O. and Clevers,H. (1998) Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol. Cell. Biol., 18, 1248–1256. · DOI
  40. Wong,M.H., Rubinfeld,B. and Gordon,J.I. (1998) Effects of forced expression of an NH2-terminal truncated beta-catenin on mouse intestinal epithelial homeostasis. J. Cell. Biol., 141, 765–777. · DOI
  41. Huber,O., Korn,R., McLaughlin,J., Ohsugi,M., Herrmann,B.G. and Kemler,R. (1996) Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev., 59, 3–10. · DOI
  42. Behrens,J., von Kries,J.P., Kuhl,M., Bruhn,L., Wedlich,D., Grosschedl,R. and Birchmeier,W. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature, 382, 638–642. · DOI · Paper page
  43. Korinek,V., Barker,N., Morin,P.J., van Wichen,D., de Weger,R., Kinzler,K.W., Vogelstein,B. and Clevers,H. (1997) Constitutive transcriptional activation by a beta-catenin–Tcf complex in APC–/– colon carcinoma. Science, 275, 1784–1787. · DOI · Paper page
  44. Morin,P.J., Sparks,A.B., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K.W. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275, 1787–1790. · DOI
  45. Shtutman,M., Zhurinsky,J., Simcha,I., Albanese,C., D'Amico,M., Pestell,R. and Ben-Ze'ev,A. (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA, 96, 5522–5527. · DOI · Paper page
  46. He,T.C., Sparks,A.B., Rago,C., Hermeking,H., Zawel,L., da Costa,L.T., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509–1512. · DOI · Paper page
  47. Ilyas,M., Tomlinson,I.P., Rowan,A., Pignatelli,M. and Bodmer,W.F. (1997) Beta-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl Acad. Sci. USA, 94, 10330–10334. · DOI
  48. Su,L.K., Kinzler,K.W., Vogelstein,B., Preisinger,A.C., Moser,A.R., Luongo,C., Gould,K.A. and Dove,W.F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668–670. [Published erratum appears in Science (1992) 256, 1114.] · DOI
  49. Shoemaker,A.R., Moser,A.R., Midgley,C.A., Clipson,L., Newton,M.A. and Dove,W.F. (1998) A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Proc. Natl Acad. Sci. USA, 95, 10826–10831. · DOI
  50. Cormier,R.T., Hong,K.H., Halberg,R.B., Hawkins,T.L., Richardson,P., Mulherkar,R., Dove,W.F. and Lander,E.S. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature Genet., 17, 88–91. · DOI
  51. Oshima,M., Dinchuk,J.E., Kargman,S.L., Oshima,H., Hancock,B., Kwong,E., Trzaskos,J.M., Evans,J.F. and Taketo,M.M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803–809. · DOI
  52. DuBois,R.N., Giardiello,F.M. and Smalley,W.E. (1996) Nonsteroidal anti-inflammatory drugs, eicosanoids and colorectal cancer prevention. Gastroenterol. Clin. N. Am., 25, 773–791. · DOI
  53. Thun,M.J., Namboodiri,M.M. and Heath,C.W.Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593–1596. · DOI
  54. Potten,C.S., Owen,G., Hewitt,D., Chadwick,C.A., Hendry,H., Lord,B.I. and Woolford,L.B. (1995) Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut, 36, 864–873. · DOI
  55. Kurokowa,M., Lynch,K. and Podolsky,D.K. (1987) Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun., 142, 775–782. · DOI
  56. Barnard,J.A., Beauchamp,R.D., Coffey,R.J. and Moses,H.L. (1989) Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc. Natl Acad. Sci. USA, 86, 1578–1582. · DOI
  57. Avery,A., Paraskeva,C., Hall,P., Flanders,K.C., Sporn,M. and Moorghen,M. (1993) TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br. J. Cancer, 68, 137–139. · DOI
  58. Koyama,S.Y. and Podolsky,D.K. (1989) Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells. J. Clin. Invest., 83, 1768–1773. · DOI
  59. Heldin,C.H., Miyazono,K. and ten Dijke,P. (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465–471. · DOI
  60. Zhou,S., Zawel,L., Lengauer,C., Kinzler,K.W. and Vogelstein,B. (1998) Characterization of human FAST-1, a TGF beta and activin signal transducer. Mol. Cell, 2, 121–127. · DOI
  61. Thiagalingam,S., Lengauer,C., Leach,F.S., Schutte,M., Hahn,S.A., Overhauser,J., Willson,J.K., Markowitz,S., Hamilton,S.R., Kern,S.E., Kinzler,K.W. and Vogelstein,B. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature Genet., 13, 343–346. · DOI
  62. Takagi,Y., Kohmura,H., Futamura,M., Kida,H., Tanemura,H., Shimokawa,K. and Saji,S. (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology, 111, 1369–1372. · DOI
  63. Eppert,K., Scherer,S.W., Ozcelik,H., Pirone,R., Hoodless,P., Kim,H., Tsui,L.C., Bapat,B., Gallinger,S., Andrulis,I.L., Thomsen,G.H., Wrana,J.L. and Attisano,L. (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543–552. · DOI
  64. Takaku,K., Oshima,M., Miyoshi,H., Matsui,M., Seldin,M.F. and Taketo,M.M. (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell, 92, 645–656. · DOI
  65. Drucker,D.J., Erlich,P., Asa,S.L. and Brubaker,P.L. (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl Acad. Sci. USA, 93, 7911–7916. · DOI
  66. Munroe,D.G., Gupta,A.K., Kooshesh,F., Vyas,T.B., Rizkalla,G., Wang,H., Demchyshyn,L., Yang,Z.J., Kamboj,R.K., Chen,H., McCallum,K., Sumner-Smith,M., Drucker,D.J. and Crivici,A. (1999) Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc. Natl Acad. Sci. USA, 96, 1569–1573. · DOI
  67. Fearon,E.R., Hamilton,S.R. and Vogelstein,B. (1987) Clonal analysis of human colorectal tumors. Science, 238, 193–197. · DOI
  68. Woodruff,M.F., Ansell,J.D., Forbes,G.M., Gordon,J.C., Burton,D.I. and Micklem,H.S. (1982) Clonal interaction in tumours. Nature, 299, 822–824. · DOI
  69. Novelli,M.R., Williamson,J.A., Tomlinson,I.P., Elia,G., Hodgson,S.V., Talbot,I.C., Bodmer,W.F. and Wright,N.A. (1996) Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science, 272, 1187–1190. · DOI
  70. Merritt,A.J., Gould,K.A. and Dove,W.F. (1997) Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc. Natl Acad. Sci. USA, 94, 13927–13931. · DOI
  71. Thomson,J.A., Itskovitz-Eldor,J., Shapiro,S.S., Waknitz,M.A., Swiergiel,J.J., Marshall,V.S. and Jones,J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147. [Published erratum appears in Science (1998) 282, 1827.] · DOI
  72. Booth,C., O'Shea,J.A. and Potten,C.S. (1999) Maintenance of functional stem cells in isolated and cultured adult intestinal epithelium. Exp. Cell Res., 249, 359–366. · DOI
  73. Petersen,B.E., Bowen,W.C., Patrene,K.D., Mars,W.M., Sullivan,A.K., Murase,N., Boggs,S.S., Greenberger,J.S. and Goff,J.P. (1999) Bone marrow as a potential source of hepatic oval cells. Science, 284, 1168–1170. · DOI

Cited by

Sorted by citations

See all 236

Metadata

Authors
Bach, S. P., Renehan, A. G., & Potten, C. S.
Venue
Carcinogenesis
Publisher
Oxford University Press (OUP)
Published
2000-03
Volume
21
Issue
3
Pages
469-476
ISSN
  • 1460-2180
  • 0143-3334
DOI
10.1093/carcin/21.3.469
Cited by
236
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review